OncoSec Medical Incorporated
Industry
- Biotechnology
- Gene Therapy, Cell Therapy
- Medical Devices
- Pharmaceuticals
- Drug Delivery
- Site Specific
- Vaccines
- Drug Delivery
Latest on OncoSec Medical Incorporated
The biopharmaceutical industry cheered Third Harmonic Bio ’s sizeable initial public offering in mid-September but the IPO market in the US has gone quiet since then as broader stock indices – includ
Initial public offerings for US biopharmaceutical companies generally slowed as 2021 drew to a close and biotechnology stock valuations continued to fall below broader stock indices. Nevertheless, thr
Inovio’s VGX-3100 Inovio Pharmaceuticals, Inc. plans to file for regulatory approval of its DNA vaccine candidate VGX-3100 for the treatment of cervical dysplasia caused by HPV 18 and 16 before the
Zydus Cadila ’s application to the Indian regulator for an accelerated nod or emergency use authorization (EUA) for its COVID-19 vaccine takes the world a step closer to the first plasmid DNA vaccine